Yoga and Total Health
Change - The Universal Constant
How to navigate it successfully
3 min |
January 2026
Yoga and Total Health
Getting on to the Starting Line
Finishing something requires that first push
4 min |
January 2026
Yoga and Total Health
The Happy Place
From outside to inside
4 min |
January 2026
Yoga and Total Health
Money Makes the World Go Round
But you can't buy happiness
2 min |
January 2026
Yoga and Total Health
Key Concepts: Therapeutic Yoga Yoga Psychology for Everyone
From healing oneself to healing others
4 min |
January 2026
Yoga and Total Health
The Exploiters of Nature
Pitfalls of the minus mind
6 min |
January 2026
Yoga and Total Health
Nishkama Karmayoga in the Bhagavad Gita
Action without self-interest - Part 6
2 min |
January 2026
Yoga and Total Health
Let's Talk About the Life of a Superwoman
And how Yoga can help
2 min |
January 2026
Yoga and Total Health
Guduchi / Giloy
This month we have a recipe using Guduchi powder.
1 min |
January 2026
Express Pharma
PRUV® -The original Sodium Stearyl Fumarate
JRS Pharma's PRUV® is the original sodium stearyl fumarate (SSF) introduced in the market over 20 years ago
5 min |
January 2026
Express Pharma
Speed and flexibility play a critical role in how we compete with larger global players
Kriti Jajoo, VP-BD and Strategy, Shriji Polymers, as the next-gen leader, speaks on how the company is evolving with a leadership approach that balances technology, sustainability, and customer-centricity to create long-term value, in an interview with Express Pharma
6 min |
January 2026
Express Pharma
Local focus to strengthen Indian pharmaceutical manufacturers
For the Indian pharmaceutical industry, competitiveness not only means access to international markets, but also establishing expertise and operational capabilities on an equal footing directly in India.
3 min |
January 2026
Express Pharma
Supriya Lifescience ramps up capacity and global readiness for next phase of growth
Recently, Supriya Lifescience expanded its manufacturing capacity at the Lote facility with the commissioning of Module E, which has enhanced operational efficiency and increased capacity utilisation from 70 per cent in FY2025 to 78 per cent in the first half of FY 2026.
4 min |
January 2026
Express Pharma
India at a jumping-off point in terms of commitment to global clinical studies
Paul Bridges, PhD, President, Consulting, Parexel, and Sanjay Vyas, President of Global Safety Services & Clinical Logistics and Country Head for India, Parexel, shortlist trends that will define 2026 from data protection uncertainty and AI governance to biosimilars' second wind, inspection readiness and India's emergence as a global clinical trials hub. Excerpts from a wide-ranging conversation with Viveka Roychowdhury
6 min |
January 2026
Express Pharma
Leadership imperative shaping India's healthcare and pharma landscape in 2026
India's rapidly growing healthcare sector now needs a new kind of leadership-one that blends scientific expertise with strategic, ethical, and digital capabilities to remain globally competitive
3 min |
January 2026
Express Pharma
Results win customers. Leadership discipline keeps them
Drawing themes from his new book The Dual Mandate in B2B - Driving Results. Shaping Culture, Mohan Joshi - Global C-Suite Partner & Former President, SCHOTT India, discusses leadership systems, alignment, and execution in conversation with Neha Aathavale.
3 min |
January 2026
Express Pharma
Beyond the ladder: Why sustainable growth needs to be T-shaped and self-driven
If one looks at the organisations that have excelled in their core operating areas and also considered as employers of choice, one will find that employee growth and development are deep rooted in the ethos of such organisations and act as strategic drivers for professional and organisational success.
5 min |
January 2026
Express Pharma
Clinical research careers: India's next big opportunity
Dr Seema Pai, President, Indian Society for Clinical Research highlights that India's clinical research sector is rapidly growing, and this growth is creating global opportunities, fostering collaboration, and opening promising career pathways for young professionals while positioning India as a future leader in clinical research
3 min |
January 2026
Express Pharma
We train professionals to see quality not as a checklist but as a mindset
Prof. Dr Syed S. Abbas, Director, Institute of Good Manufacturing Practices India (IGMPI), explains how globally benchmarked programmes, hands-on learning, industry-aligned curricula, and flexible training models are preparing professionals to meet global compliance expectations and strengthen India's position as a hub for safe, high-quality pharma products, in an interaction with Kalyani Sharma
4 min |
January 2026
Express Pharma
Next year, resilience will bubble up as a critical business objective
As pharma R&D becomes more digital, cloud-driven and Al-enabled, cyber risk is fast emerging as a boardroom priority. Rajnish Gupta, MD & Country Manager, Tenable India, explains why resilience, not just prevention, will define pharma cybersecurity strategies in 2026 and beyond, in an interview with Viveka Roychowdhury
4 min |
January 2026
Express Pharma
The next wave of growth will belong not to the fastest manufacturers but to the most innovative problem-solvers
As India moves into 2026, industry experts state that the next phase of growth in pharmaceuticals will depend on strengthening formulation R&D, building a skilled and adaptable workforce, and closing gaps between academic research and industry needs.
6 min |
January 2026
Express Pharma
Good pharma-focused developers are now co-designing with GMP/WHO/USFDA consultants from day zero
In a post-pandemic world, pharma real estate has evolved from a cost decision to a strategic one.
5 min |
January 2026
Express Pharma
Future of pharma: Trends, challenges & AI
Industry experts discussed how Al is transforming pharmaceutical R&D, highlighting both the promise and the practical limitations of current technologies
2 min |
January 2026
Express Pharma
Pharcos Speciality's Daman plant secures WHO-GMP certification
The certification underscores Pharcos' adherence to globally recognised quality standards, safety, and regulatory compliance, strengthening its position as a trusted manufacturer of excipients
2 min |
January 2026
Express Pharma
Local manufacturing is not just a priority— it is a national commitment
Frehiwot Abebe, State Minister, Ministry of Health, Ethiopia, and Bhavin Mukund Mehta, Vice Chairman, Pharmexcil, discuss Ethiopia's evolving pharma ecosystem.
4 min |
January 2026
Express Pharma
We are cost-competitive and aligned with global ESG framework demands
From dependence on imported single-use products and containment solutions, India's biologics sector can today access domestically manufactured SUTs, which can be 20–30 per cent more cost-effective than imported counterparts.
5 min |
January 2026
Express Pharma
Pharma trends that will shape 2026: Building a future-ready, patient-centric industry
Anil Matai, Director General, OPPI, outlines the major pharmaceutical trends expected to shape 2026, detailing how digital health, Al-driven drug development, precision medicine and resilient supply chains will influence the industry's shift towards a future-ready, patient-centric ecosystem
3 min |
January 2026
Express Pharma
INDIA'S INNOVATION JOURNEY FROM PROMISE TO PROOF
India's pharma ecosystem is ready to embrace stronger science and bolder ideas. Turning early breakthroughs into scalable, sustainable innovation remains the challenge
8 min |
January 2026
Express Pharma
Odisha's pharma pitch
The inaugural Odisha Pharma Summit 2025 delivered strong early signals of intent, positioning the state as an upcoming destination for PLI-triggered expansions, to complement existing pharma hubs. As Hemant Sharma, ACS Industry Dept and I&PR Dept, Govt of Odisha puts it, the aim is to “become a good, viable second option.” How fast can the eastern newcomer catch up and become India's next life sciences hub, asks Viveka Roychowdhury
5 min |
January 2026
Express Pharma
Can Indian biosimilars and generics restate accessibility in global underserved markets?
Hari Kiran Chereddi, MD & CEO - HRV Pharma & NHG Pharma highlights that India's success in generics is no longer enough, as the world now demands advanced biologics, biosimilars, and personalised medicines. He further emphasises on the need for stronger regulation, innovation, and investment so India can lead in next-generation therapies and expand global access to cutting-edge healthcare
3 min |